This study characterizes the role of specialty drug utilization in aggregate private sector healthcare spending in the United States from 2000 to 2009.
Seth A. Seabury, PhD
Advertisement
Articles by Seth A. Seabury, PhD
Advertisement
Latest Updated Articles
- The Role of Specialty Drugs in Private Sector Healthcare Spending
Published: December 5th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Cholesterol-HDL-Glucose Index Linked to Type 2 Diabetes Prevalence in Adults
4
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
5
